 cardiac disturb administr taxol clinic develop taxol new antimicrotubul agent uniqu mechan cytotox action due seriou hypersensit reaction hsr suppli large-scal phase II trial taxol impress activ advanc cisplatin-refractori ovarian carcinoma incid hsr premed modif administr schedul variou manifest potenti cardiotox sever patient phase II studi taxol asymptomat bradycardia high proport patient ovarian cancer patient dose taxol phase II studi profound cardiac disturb rang atrioventricular conduct block bundl branch block ventricular tachycardia VT manifest cardiac ischemia patient taxol descript event report investig potenti advers effect disturb seriou sequela patient investig high degre caution precis risk factor frequenc clinic signific advers cardiac effect